Citations for
1GPR183
EBI2 contributes to the induction of thymic central tolerance in mice by promoting rapid motility of medullary thymocytes.
Ki S, Thyagarajan HM, Hu Z, Lancaster JN, Ehrlich LIR.
Eur J Immunol 47(11):1906-1917. doi: 10.1002/eji.201747020. Epub 2017 Aug 9. 2017
2GPR183
EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and Promotes Early CNS Migration of Encephalitogenic CD4 T Cells.
Wanke F, Moos S, Croxford AL, Heinen AP, Gräf S, Kalt B, Tischner D, Zhang J, Christen I, Bruttger J, Yogev N, Tang Y, Zayoud M, Israel N, Karram K, Reißig S, Lacher SM, Reichhold C, Mufazalov IA, Ben-Nun A, Kuhlmann T, Wettschureck N, Sailer AW, Rajewsky K, Casola S, Waisman A, Kurschus FC.
Cell Rep 18(5):1270-1284. doi: 10.1016/j.celrep.2017.01.020. 2017
3GPR183
EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.
Niss Arfelt K, Barington L, Benned-Jensen T, Kubale V, Kovalchuk AL, Daugvilaite V, Christensen JP, Thomsen AR, Egerod KL, Bassi MR, Spiess K, Schwartz TW, Wang H, Morse HC 3rd, Holst PJ, Rosenkilde MM.
Blood 129(7):866-878. doi: 10.1182/blood-2016-02-697185. Epub 2016 Dec 21. 2017
4GPR183
EBI2 expression in B lymphocytes is controlled by the Epstein-Barr virus transcription factor, BRRF1 (Na), during viral infection.
Cornaby C, Jafek JL, Birrell C, Mayhew V, Syndergaard L, Mella J, Cheney W, Poole BD.
J Gen Virol 98(3):435-446. doi: 10.1099/jgv.0.000660. Epub 2017 Mar 20. 2017
5GPR183
EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells.
Li J, Lu E, Yi T, Cyster JG.
Nature 533(7601):110-4. doi: 10.1038/nature17947. 2016
6GPR183
The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems.
Rutkowska A, Dev KK, Sailer AW.
Curr Drug Targets 17(16):1851-1860. Review. 2016
7GPR183
Oxysterols and EBI2 promote osteoclast precursor migration to bone surfaces and regulate bone mass homeostasis.
Nevius E, Pinho F, Dhodapkar M, Jin H, Nadrah K, Horowitz MC, Kikuta J, Ishii M, Pereira JP.
J Exp Med 212(11):1931-46. doi: 10.1084/jem.20150088. Epub 2015 Oct 5. 2015
8GPR183
G protein-coupled receptor 183 facilitates endothelial-to-hematopoietic transition via Notch1 inhibition.
Zhang P, He Q, Chen D, Liu W, Wang L, Zhang C, Ma D, Li W, Liu B, Liu F.
Cell Res 25(10):1093-107. doi: 10.1038/cr.2015.109. Epub 2015 Sep 11. 2015
9GPR183
EBI2 regulates intracellular signaling and migration in human astrocyte.
Rutkowska A, Preuss I, Gessier F, Sailer AW, Dev KK.
Glia 63(2):341-51. doi: 10.1002/glia.22757. Epub 2014 Oct 9. 2015
10GPR183
Transcriptional regulation and functional characterization of the oxysterol/EBI2 system in primary human macrophages.
Preuss I, Ludwig MG, Baumgarten B, Bassilana F, Gessier F, Seuwen K, Sailer AW.
Biochem Biophys Res Commun 446(3):663-8. doi: 10.1016/j.bbrc.2014.01.069. Epub 2014 Jan 27. 2014
11GPR183
EBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cells.
Chiang EY, Johnston RJ, Grogan JL.
PLoS One 8(12):e83457. doi: 10.1371/journal.pone.0083457. eCollection 2013. 2013
12GPR183
EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture.
Yi T, Cyster JG.
Elife 2:e00757. doi: 10.7554/eLife.00757. 2013
13GPR183
The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells.
Gatto D, Wood K, Caminschi I, Murphy-Durland D, Schofield P, Christ D, Karupiah G, Brink R.
Nat Immunol 14(5):446-53. doi: 10.1038/ni.2555. Epub 2013 Mar 17. Erratum in: Nat Immunol. 2013 Aug;14(8):876. 2013
14GPR183
Molecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183).
Benned-Jensen T, Norn C, Laurent S, Madsen CM, Larsen HM, Arfelt KN, Wolf RM, Frimurer T, Sailer AW, Rosenkilde MM.
J Biol Chem 287(42):35470-83. doi: 10.1074/jbc.M112.387894. Epub 2012 Aug 8. 2012
15GPR183
Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site.
Zhang L, Shih AY, Yang XV, Kuei C, Wu J, Deng X, Mani NS, Mirzadegan T, Sun S, Lovenberg TW, Liu C.
Mol Pharmacol 82(6):1094-103. doi: 10.1124/mol.112.080275. Epub 2012 Aug 28. 2012
16GPR183
EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center.
Gatto D, Wood K, Brink R.
J Immunol 187(9):4621-8. doi: 10.4049/jimmunol.1101542. Epub 2011 Sep 23. 2011
17GPR183
EBI2 mediates B cell segregation between the outer and centre follicle.
Pereira JP, Kelly LM, Xu Y, Cyster JG.
Nature 460(7259):1122-6. Epub 2009 Jul 13. 2009
18GPR183
Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses.
Gatto D, Paus D, Basten A, Mackay CR, Brink R.
Immunity 31(2):259-69. doi: 10.1016/j.immuni.2009.06.016. Epub 2009 Jul 16. 2009
19GPR183
Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity.
Rosenkilde MM, Benned-Jensen T, Andersen H, Holst PJ, Kledal TN, Lüttichau HR, Larsen JK, Christensen JP, Schwartz TW.
J Biol Chem 281(19):13199-208. Epub 2006 Mar 15. 2006
20GPR183
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupledpeptide receptors.
Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E.
J Virol 67(4):2209-20. 1993